ArticleJournal of cancer research and clinical oncology2019

Prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers.

Nathaniel Melling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.